190 related articles for article (PubMed ID: 26210521)
21. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
[TBL] [Abstract][Full Text] [Related]
22. Selective use of sentinel lymph node surgery during prophylactic mastectomy.
Boughey JC; Khakpour N; Meric-Bernstam F; Ross MI; Kuerer HM; Singletary SE; Babiera GV; Arun B; Hunt KK; Bedrosian I
Cancer; 2006 Oct; 107(7):1440-7. PubMed ID: 16955504
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
24. Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience.
Unukovych D; Sandelin K; Wickman M; Arver B; Johansson H; Brandberg Y; Liljegren A
Acta Oncol; 2012 Sep; 51(7):934-41. PubMed ID: 22409595
[TBL] [Abstract][Full Text] [Related]
25. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
[TBL] [Abstract][Full Text] [Related]
26. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
[TBL] [Abstract][Full Text] [Related]
27. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
[TBL] [Abstract][Full Text] [Related]
28. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
29. Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy.
Scott CI; Iorgulescu DG; Thorne HJ; Henderson MA; Phillips KA;
Clin Genet; 2003 Aug; 64(2):111-21. PubMed ID: 12859406
[TBL] [Abstract][Full Text] [Related]
30. Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact.
Bouchard-Fortier A; Baxter NN; Sutradhar R; Fernandes K; Camacho X; Graham P; Quan ML
Curr Oncol; 2018 Dec; 25(6):e562-e568. PubMed ID: 30607124
[TBL] [Abstract][Full Text] [Related]
31. Breast conservation in patients with multiple ipsilateral synchronous cancers.
Kaplan J; Giron G; Tartter PI; Bleiweiss IJ; Estabrook A; Smith SR
J Am Coll Surg; 2003 Nov; 197(5):726-9. PubMed ID: 14585405
[TBL] [Abstract][Full Text] [Related]
32. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
Kruper L; Kauffmann RM; Smith DD; Nelson RA
Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
[TBL] [Abstract][Full Text] [Related]
33. Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.
Schott S; Vetter L; Keller M; Bruckner T; Golatta M; Eismann S; Dikow N; Evers C; Sohn C; Heil J
Arch Gynecol Obstet; 2017 Jun; 295(6):1451-1458. PubMed ID: 28439664
[TBL] [Abstract][Full Text] [Related]
34. [Breast carcinoma: value of adjuvant therapy after mastectomy? Overview of personal results over > or = 20 years].
Schwegler N; Puric E
Praxis (Bern 1994); 2002 Sep; 91(38):1541-51. PubMed ID: 12369221
[TBL] [Abstract][Full Text] [Related]
35. Routine prophylactic sentinel lymph node biopsy is not indicated in women undergoing prophylactic mastectomy.
Czyszczon IA; Roland L; Sahoo S
J Surg Oncol; 2012 Jun; 105(7):650-4. PubMed ID: 22213101
[TBL] [Abstract][Full Text] [Related]
36. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
37. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer.
Terenziani M; Massimino M; Magazzù D; Gandola L; Capri G; Carcangiu ML; Catania S; Di Russo A; Gennaro M; Meazza C; Podda M; Schiavello E; Valagussa P
Eur J Cancer; 2015 Sep; 51(13):1667-74. PubMed ID: 26092639
[TBL] [Abstract][Full Text] [Related]
38. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction.
Koslow S; Pharmer LA; Scott AM; Stempel M; Morrow M; Pusic AL; King TA
Ann Surg Oncol; 2013 Oct; 20(11):3422-9. PubMed ID: 23720070
[TBL] [Abstract][Full Text] [Related]
39. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
40. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
